Protein levels of human peroxiredoxin subtypes in brains of patients with Alzheimer’s disease and Down Syndrome

  • S. H. Kim
  • M. Fountoulakis
  • N. Cairns
  • G. Lubec


Human peroxiredoxin (Prx) play important roles in eliminating hydrogen peroxide generated during cellular mechanisms using electrons from thioredoxin (Trx). Oxidative stress induced by reactive oxygen species (ROS) such as hydrogen peroxide has been implicated in the pathogenesis of several neurodegenerative diseases. We applied the proteomic approach to study protein levels of three subtypes of human Prx in brain regions from patients with Alzheimer’s disease (AD) and Down Syndrome (DS). Protein levels of Prx-I and Prx-II were significantly increased in AD and DS. Protein levels of Prx-III, a mitochondrial protein, however, were significantly decreased. We conclude that increased protein levels of Prx-I and Prx-II could provide protection against neuronal cell death induced by hydrogen peroxide. Decreased protein levels of Prx-III could be caused by mitochondrial damage shown in AD and DS. Showing upregulated Prx protein levels provides evidence for the involvement of ROS in the pathogenesis of AD and DS.


Down Syndrome Mitochondrial Permeability Transition Down Syndrome Patient Decrease Protein Level Graphpad Instat2 Software 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Adler V, Yin Z, Tew KD, Ronai Z (1999) Role of redox potential and reactive oxygen species in stress signaling. Oncogene 18: 222: 6104–6111PubMedCrossRefGoogle Scholar
  2. Araki M, Nanri H, Ejima K, Murasato Y, Fujiwara T, Nakashima Y, Ikeda M (1999) Antioxidant function of the mitochondrial protein SP-22 in the cardiovascular system. J Biol Chem 274: 2271–2278PubMedCrossRefGoogle Scholar
  3. Aylward EH, Habbak R, Warren AC, Pulsifer MB, Barta PE, Jerram M, Pearlson GD (1997) Cerebellar volume in adults with Down syndrome. Arch Neurol 54: 209–212PubMedCrossRefGoogle Scholar
  4. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248–254PubMedCrossRefGoogle Scholar
  5. Brugge K, Nichols S, Saitoh T, Trauner D (1999) Correlations of glutathione peroxidase activity with memory impairment in adults with Down syndromes. Biol Psychiatry 46: 1682–1689PubMedCrossRefGoogle Scholar
  6. Busciglio J, Yankner BA (1995) Apoptosis and increased generation of reactive oxygen species in Down’s syndrome neurons in vitro. Nature 378: 776–779PubMedCrossRefGoogle Scholar
  7. Cairns NJ (1999) Neuropathology. J Neural Transm [Suppl] 57: 61–74Google Scholar
  8. Chae HZ, Chung SJ, Rhee SG (1994a) Thioredoxin-dependent peroxide reductase from yeast. J Biol Chem 269: 27670–27678PubMedGoogle Scholar
  9. Chae HZ, Robison K, Poole LB, Church G, Storz G, Rhee SG (1994b) Cloning and sequencing of thio-specific antioxidant from mammalian brain: alkyl hydroperoxide reductase and thio-specific antioxidant define a large family of antioxidant enzymes. Proc Natl Acad Sci USA 91: 7017–7021PubMedCrossRefGoogle Scholar
  10. Chae HZ, Kang SW, Rhee SG (1999) Isoforms of mammalian peroxiredoxin that reduce peroxides in presence of thioredoxin. Methods Enzymol 300: 219–226PubMedCrossRefGoogle Scholar
  11. Chen QM, Tu VC, Wu Y, Bahl JJ (2000) Hydrogen peroxide dose dependent induction of cell death or hypertrophy in cardiomyocytes. Arch Biochem Biophys 373: 242–248PubMedCrossRefGoogle Scholar
  12. de la Monte SM (1999) Molecular abnormalities of the brain in Down syndrome: relevance to Alzheimer’s neurodegeneration. J Neural Transm [Suppl] 57: 1–19Google Scholar
  13. Fountoulakis M, Langen H (1997) Identification of proteins by matrix-assisted laser desorption ionization-mass spectrometry following in-gel digestion in low-salt, nonvolatile buffer and simplified peptide recovery. Anal Biochem 250: 153–156PubMedCrossRefGoogle Scholar
  14. Fullerton HJ, Ditelberg JS, Chem SF, Sarco DP, Chan PH, Epstein CJ, Ferriero DM (1998) Copper/zinc superoxide dismutase transgenic brain accumulates hydrogen peroxide after perinatal hypoxia ischemia. Ann Neurol 44: 357–364PubMedCrossRefGoogle Scholar
  15. Gerli G, Zenoni L, Locatelli GF, Mongiat R, Piattoni F, Orsini GB, Montagnani A, Gueli MR, Gualandri V (1990) Erythrocyte antioxidant system in Down syndrome. Am J Med Genet [Suppl] 7: 272–273Google Scholar
  16. Greber S, Lubec G, Cairns N, Fountoulakis M (1999) Decreased levels of synaptosomal associated protein 25 in the brain of patients with Down syndrome and Alzheimer’s disease. Electrophoresis 20: 928–934PubMedCrossRefGoogle Scholar
  17. Gutteridge JM (1994) Biological origin of free radicals and mechanisms of antioxidant protection. Chem Biol Interact 91: 133–140PubMedCrossRefGoogle Scholar
  18. Halliwell B (1999) Antioxidant defence mechanisms: from the beginning to the end (of the beginning). Free Rad Res 31: 261–272CrossRefGoogle Scholar
  19. Hayes JD, McLellan LI (1999) Glutathione and glutathione-dependent enzymes represent a co-ordinately regulated defence against oxidative stress. Free Rad Res 31: 273–300CrossRefGoogle Scholar
  20. Hoyt KR, Gallagher AJ, Hastings TG, Reynolds IJ (1997) Characterization of hydrogen peroxide toxicity in cultured rat forebrain neurons. Neurochem Res 22: 333–340PubMedCrossRefGoogle Scholar
  21. Ichimiya S, Davis JG, O’Rourke DM, Katsumata M, Greene MI (1997) Murine thioredoxin peroxidase delays neuronal apoptosis and is expressed in areas of the brain most susceptible to hypoxic and ischemic injury. DNA Cell Biol 16: 311–321PubMedCrossRefGoogle Scholar
  22. Jovanovic SV, Clements D, MacLeod K (1998) Biomarkers of oxidative stress are significantly elevated in Down syndrome. Free Radic Biol Med 25: 1044–1048PubMedCrossRefGoogle Scholar
  23. Kang SW, Baines I, Rhee SG (1998a) Characterization of a mammalian peroxiredoxin that contains one conserved cysteine. J Biol Chem 273: 6303–6311PubMedCrossRefGoogle Scholar
  24. Kang SW, Chae HZ, Seo MS, Kim K, Baines IC, Rhee SG (1998b) Mammalian peroxiredoxin isoforms can reduce hydrogen peroxide generated in response to growth factors and tumor necrosis factor-alpha. J Biol Chem 273: 6297–6302PubMedCrossRefGoogle Scholar
  25. Kanno S, Ishikawa M, Takayanagi M, Takayanagi Y, Sasaki M (1999) Exposure to hydrogen peroxide induces cell death via apoptosis in primary cultured mouse hepatocytes. Biol Pharm Bull 22: 1296–1300PubMedCrossRefGoogle Scholar
  26. Kim SH, Vlkolinsky R, Cairns N, Fountoulakis M, Lubec G (2001) The reduction of NADH: ubiquinone oxidoreductase 24- and 75-kDa subunits in brains of patients with Down syndrome and Alzheimer’s disease. Life Sci 68: 2741–2750PubMedCrossRefGoogle Scholar
  27. Kim SH, Vlkolinsky R, Cairns N, Lubec G (2000) Decreased protein levels of complex III core protein 1 and complex V beta chain. Cell Mol Life Sci 57: 1810–1816PubMedCrossRefGoogle Scholar
  28. Kowaltowski AJ, Netto LES, Vercesi AE (1998) The thiol-specific antioxidant enzyme prevents mitochondrial permeability transition. J Biol Chem 273: 12766–12769PubMedCrossRefGoogle Scholar
  29. Langen H, Roder D, Juranville JF, Fountoulakis M (1997) Effect of protein application mode and acrylamide concentration on the resolution of protein spots separated by two-dimensional gel electrophoresis. Electrophoresis 18: 2085–2090PubMedCrossRefGoogle Scholar
  30. Langen H, Berndt P, Roder D, Cairns N, Lubec G, Fountoulakis M (1999) Two-dimensional map of human brain proteins. Electrophoresis 20: 907–916PubMedCrossRefGoogle Scholar
  31. McBride AG, Borutaite V, Brown GC (1999) Superoxide dismutase and hydrogen peroxide cause rapid nitric oxide breakdown, peroxynitrite production and subsequent cell death. Biochim Biophys Acta 1454: 275–288PubMedCrossRefGoogle Scholar
  32. Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM, Vogel FS, Hughes JP, van Belle G, Berg L (1991) The Consortium to Establish a Registry for Alzheimer’s Disease (CERAD), part II. Standardization of the neuropathologic assessment of Alzheimer’s disease. Neurology 41: 479–486PubMedCrossRefGoogle Scholar
  33. Nagy Zs (1999) Mechanisms of neuronal death in Down’s syndrome. J Neural Transm [Suppl] 57: 233–245Google Scholar
  34. Okado-Matsumoto A, Matsumoto A, Fujii J, Taniguchi N (2000) Peroxiredoxin IV is a secretable protein with heparin-binding properties under reduced conditions. J Biochem 127: 493–501PubMedCrossRefGoogle Scholar
  35. Pappolla MA, Omar RA, Kim KS, Robakis NK (1992) Immunohistochemical evidence of oxidative [corrected] stress in Alzheimer’s disease. Am J Pathol 140: 621–628PubMedGoogle Scholar
  36. Percy ME, Dalton AJ, Markovic VD, McLachlan DR, Hummel JT, Rusk AC, Andrews DF (1990) Red cell superoxide dismutase, glutathione peroxidase and catalase in Down syndrome patients with and without manifestations of Alzheimer’s disease. Am J Med Genet 35: 459–467PubMedCrossRefGoogle Scholar
  37. Perrin R, Briancon S, Jeandel C, Artur Y, Minn A, Penin F, Siest G (1990) Blood activity of Cu/Zn superoxide dismutase, glutathione peroxidase and catalase in Alzheimer’s disease: a case-control study. Gerontology 36: 306–313PubMedCrossRefGoogle Scholar
  38. Pierce GB, Parchment RE, Lewellyn AL (1991) Hydrogen peroxide as a mediator of programmed cell death in the blastocyst. Differentiation 46: 181–186PubMedCrossRefGoogle Scholar
  39. Richter-Landsberg C, Vollgraf U (1998) Mode of cell injury and death after hydrogen peroxide exposure in cultured Oligodendroglia cells. Exp Cell Res 244: 218–229PubMedCrossRefGoogle Scholar
  40. Sarafian TA, Rajper N, Grigorian B, Kim A, Shau H (1997) Cellular antioxidant properties of human natural killer enhancing factor B. Free Radic Res 26: 281–289PubMedCrossRefGoogle Scholar
  41. Sarafian TA, Huang C, Kim A, de Velli J, Shau H (1998) Expression of the antioxidant gene NKEF in the central nervous system. Mol Chem Neuropathol 34: 39–51PubMedCrossRefGoogle Scholar
  42. Sarafian TA, Verity MA, Vinters HV, Shih CC, Shi L, Ji XD, Dong L, Shau H (1999) Differential expression of peroxiredoxin subtypes in human brain cell types. J Neurosci Res 56: 206–212PubMedGoogle Scholar
  43. Sauri H, Butterfield L, Kim A, Shau H (1995) Antioxidant function of recombinant human natural killer enhancing factor. Biochem Biophys Res Commun 208: 964–969PubMedCrossRefGoogle Scholar
  44. Sawa A (1999) Neuronal cell death in Down’s syndrome. J Neural Transm [Suppl] 57: 87–97Google Scholar
  45. Shau H, Kim A (1994) Identification of natural killer enhancing factor as a major antioxidant in human red blood cells. Biochem Biophys Res Commun 199: 83–88PubMedCrossRefGoogle Scholar
  46. Shau H, Gupta RK, Golub SH (1993) Identification of a natural killer enhancing factor (NKEF) from human erythroid cells. Cell Immunol 147: 1–11PubMedCrossRefGoogle Scholar
  47. Shau H, Kim AT, Hedrick CC, Lusis AJ, Tompkins C, Finney R, Leung DW, Paglia DE (1997) Endogenous natural killer enhancing factor-B increases cellular resistance to oxidative stresses. Free Radic Biol Med 22: 497–507PubMedCrossRefGoogle Scholar
  48. Simonian NA, Coyle JT (1996) Oxidative stress in neurodegenerative diseases. Annu Rev Pharmacol Toxicol 36: 83–106PubMedCrossRefGoogle Scholar
  49. Tierney MC, Fisher RH, Lewis AJ, Zorzitto ML, Snow WG, Reid DW, Nieuwstraten P (1988) The NINCDS-ADRDA Work Group criteria for the clinical diagnosis of probable Alzheimer’s disease: a clinicopathologic study of 57 cases. Neurology 38: 359–364PubMedCrossRefGoogle Scholar
  50. Tsuji K, Copeland NG, Jenkins NA, Obinata N (1995) Mammalian antioxidant protein complements alkylhydroperoxide reductase (ahpC) mutation in Escherichia coli. Biochem J 307: 377–381PubMedGoogle Scholar
  51. Vollgraf U, Wegner M, Richter-Landsberg C (1999) Activation of AP-1 and nuclear factor-kappaB transcription factors is involved in hydrogen peroxide-induced apoptotic cell death of oligodendrocytes. J Neurochem 73: 2501–2509-PubMedCrossRefGoogle Scholar
  52. Watabe S, Kohno H, Kouyama H, Hiroi T, Yago N, Nakazawa T (1994) Purification and characterization of a substrate protein for mitochondrial ATP-dependent protease in bovine adrenal cortex. J Biochem (Tokyo) 115: 648–654Google Scholar
  53. Watabe S, Hasegawa H, Takimoto K, Yamamoto Y, Takahashi SY (1995) Possible function of SP-22, a substrate of mitochondrial ATP dependent protease, as a radical scavenger. Biochem Biophys Res Commun 213: 1010–1016PubMedCrossRefGoogle Scholar
  54. Watabe S, Hiroi T, Yamamoto Y, Fujioka K, Hasegawa H, Yago N, Takahashi SY (1997) SP-22 is a thioredoxin-dependent peroxide reductase in mitochondria. Eur J Biochem 249: 52–60PubMedCrossRefGoogle Scholar
  55. Whittemore ER, Loo DT, Cotman CW (1994) Exposure to hydrogen peroxide induces cell death via apoptosis in cultured rat cortical neurons. Neuroreport 5: 1485–1488PubMedCrossRefGoogle Scholar
  56. Whittemore ER, Loo DT, Watt JA, Cotman CW (1995) A detailed analysis of hydrogen peroxide-induced cell death in primary neuronal culture. Neuroscience 67: 921–932PubMedCrossRefGoogle Scholar
  57. Yamamoto Y, Matsui Y, Natori S, Obinata M (1989) Cloning of a housekeeping-type gene (MER5) preferentially expressed in murine erythroleukemia cells. Gene 80: 337–343PubMedCrossRefGoogle Scholar
  58. Zang P, Liu B, Kang SW, Seo MS, Rhee SG, Obeid LM (1997) Thioredoxin peroxidase is a novel inhibitor of apoptosis with a mechanism distinct from that of Bcl-2. J Biol Chem 272: 30615–30618CrossRefGoogle Scholar
  59. Zhou Y, Kok KH, Chun AC, Wong CM, Wu HW, Lin MC, Fung PC, Kung H, Jin DY (2000) Mouse peroxiredoxin V is a thioredoxin peroxidase that inhibits p53-induced apoptosis. Biochem Biophys Res Commun 268: 921–927PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag/Wien 2001

Authors and Affiliations

  • S. H. Kim
    • 1
  • M. Fountoulakis
    • 2
  • N. Cairns
    • 3
  • G. Lubec
    • 1
  1. 1.Department of PediatricsUniversity of ViennaAustria
  2. 2.F. Hoffmann - La RocheBaselSwitzerland
  3. 3.Institute of Psychiatry, Brain BankKing’s CollegeUK

Personalised recommendations